Weesp, Netherlands

Jan G Koper

This inventor holds 1 USPTO granted patent. Top assignee: Cedona Pharmaceuticals B.v.. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jan G Koper. Retrieved from https://idiyas.com/inventor/jan-g-koper

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jan G Koper: Innovator in Pharmaceutical Compounds

Introduction

Jan G Koper is a notable inventor based in Weesp, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds and processes for preparing substituted or unsubstituted compounds. His innovative work has led to the granting of a patent, showcasing his expertise and dedication to advancing medical science.

Latest Patents

Jan G Koper holds a patent for "Compounds and process preparing a substituted or an unsubstituted." This patent reflects his commitment to creating effective pharmaceutical solutions. With 1 patent to his name, Koper's work is recognized within the industry for its potential impact on drug development.

Career Highlights

Koper is currently associated with Cedona Pharmaceuticals B.V., a company focused on pharmaceutical innovations. His role at Cedona allows him to apply his knowledge and skills in a collaborative environment, contributing to the company's mission of advancing healthcare solutions.

Collaborations

Throughout his career, Jan G Koper has worked alongside talented professionals, including John C Eriks and Henderikus Van Der Goot. These collaborations have enriched his experience and fostered a creative atmosphere for innovation.

Conclusion

Jan G Koper is a distinguished inventor whose work in pharmaceutical compounds has made a notable impact. His patent and collaborations reflect his commitment to advancing medical science and improving healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…